Acupuncture and laser acupuncture treatment for diabetic peripheral neuropathy. A double-blind placebo controlled design in acupuncture research.

Acupuncture and laser acupuncture treatment for diabetic peripheral neuropathy. A double-blind placebo controlled design in acupuncture research. - ACUDIN

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00008562

Enrollment

180

Registered

2015-06-29

Start date

2011-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G63.2

Interventions

Group 1: Classical needle acupuncture (verum), 10 treatment sessions of 20 minutes, once weekly for 10 weeks Group 2: Verum Laser acupuncture (Laser on), 10 treatment sessions of 20 minutes, once week

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients diagnosed with diabetes mellitus type 2 and stable levels of HbA1c (deviation < 1% during the last 6 months), clinically assured diabetic peripheral neuropathy and pathologic results in nerve conduction studies of tibial nerve and sural nerve will be included.

Exclusion criteria

Exclusion criteria: Other diseases than diabetes that may cause peripheral neuropathy; History of epilepsy; Coagulopathy or use of anticoagulants with bleeding time > 3 min, prothrombin time 50 sec; Bacterial infection or other skin diseases at the lower extremities; Bone fracture of the lower extremities during the last three months; Alcohol, opiat, analgetic, or drug abuse; Psychiatric illnesses other than mild depression; Incapacity of following the study instructions ;(severe language disturbances, serious cognitive deficits, lack of time); Pregnant or breast-feeding women; Current participation in other clinical studies.

Design outcomes

Primary

Measure	Time frame
Pre-post comparison of the sensory sural nerve action potential amplitude (SNAP) before and 4 weeks after the treatment (week 0 and 14) by nerve conduction studies	—

Secondary

Measure	Time frame
Pre-post comparison of sensory sural nerve conduction velocity, motor tibial nerve action potential amplitude and motor tibial nerve conduction velocity by nerve conduction studies; pre-post comparison of Neuropathic Deficit Score (NDS) and Neuropathic Symptom Score (NSS) as well as of subjective complaints by visual analogue scales (VAS) before and 4 weeks after the treatment (week 0 and week 14)	—

Measure

Time frame

Pre-post comparison of sensory sural nerve conduction velocity, motor tibial nerve action potential amplitude and motor tibial nerve conduction velocity by nerve conduction studies; pre-post comparison of Neuropathic Deficit Score (NDS) and Neuropathic Symptom Score (NSS) as well as of subjective complaints by visual analogue scales (VAS) before and 4 weeks after the treatment (week 0 and week 14)

—

Countries

Germany

Contacts

Public ContactSven Schroeder

HanseMerkur Zentrum für Traditionelle Chinesische Medizin am Universitätsklinikum Hamburg-Eppendorf

praxis@tcm-m-uke.de+49 40 413 57 990

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 7, 2026